Ryan J. Selhorn

CFO

US·SEC (Form 4)

Aytu Biopharma, Inc

Total declarations

Company

▲ Purchases (0 ops.)

—

▼ Sales (0 ops.)

—

Latest filing published 30 Jul 2026 for Aytu Biopharma, INC. Read the official filing

Insider track record

Disclosed buys

Disclosed sells

Not enough buy signals with a settled T+90 horizon to measure a track record yet.

Signal history

No signal scores available.

Ryan J. Selhorn: trading record in brief

Ryan J. Selhorn appears in our data through filings on Aytu Biopharma, Inc shares, published by SEC (Form 4). We count 5 filings; the first trade dates from 11 November 2024 and the latest from 28 July 2026.

None of the filings is a plain purchase or sale on the open market; they cover grants, option exercises and other movements. Compensation-driven entries like these are tracked, but they say little about how insiders judge the share price.

Most recently, on 30 July 2026, the filings show a share grant in Aytu Biopharma, Inc. Filings reach the SEC (Form 4) feed a median of 4 days after the trade. The legal deadline for a Form 4 is two business days after the transaction. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.